TY - JOUR
T1 - Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients
AU - Fogari, R.
AU - Mugellini, A.
AU - Zoppi, A.
AU - Lazzari, P.
AU - Destro, M.
AU - Rinaldi, A.
AU - Preti, P.
PY - 2006/3
Y1 - 2006/3
N2 - The aim of this study was to compare the effects of telmisartan/ hydrochlorothiazide (HCTZ) vs lisinopril/HCTZ combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients. A total of 160 patients, 76 men and 84 women, aged 61-75 years, with sitting diastolic blood pressure (DBP) >90mmHg and 140mmHg were randomized to receive temisartan 80 mg/HCTZ 12.5mg o.d. or lisinopril 20 mg/HCTZ 12.5mg o.d. for 24 weeks, according to a prospective, open-label, blinded end point, parallelgroup design. At the end of a 2-week wash-out period and after 12 and 24 weeks of active treatment, 24-h noninvasive ambulatory BP monitoring (ABPM) was performed and cognitive function was evaluated through six different tests (verbal fluency, Boston naming test, word-list memory, word-list recall, wordlist recognition and Trails B). Both treatments significantly reduced ambulatory BP. However, the telmisartan/HCTZ combination produced a greater reduction in 24-h, day-time and night time ABPM values. Lisinopril/HCTZ did not induce significant changes in any of the cognitive function test scores at any time of the study, whereas at both 12 and 24 weeks telmisartan/HCTZ significantly improved the word-list memory score (+17.1 and +15.7%, respectively, P
AB - The aim of this study was to compare the effects of telmisartan/ hydrochlorothiazide (HCTZ) vs lisinopril/HCTZ combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients. A total of 160 patients, 76 men and 84 women, aged 61-75 years, with sitting diastolic blood pressure (DBP) >90mmHg and 140mmHg were randomized to receive temisartan 80 mg/HCTZ 12.5mg o.d. or lisinopril 20 mg/HCTZ 12.5mg o.d. for 24 weeks, according to a prospective, open-label, blinded end point, parallelgroup design. At the end of a 2-week wash-out period and after 12 and 24 weeks of active treatment, 24-h noninvasive ambulatory BP monitoring (ABPM) was performed and cognitive function was evaluated through six different tests (verbal fluency, Boston naming test, word-list memory, word-list recall, wordlist recognition and Trails B). Both treatments significantly reduced ambulatory BP. However, the telmisartan/HCTZ combination produced a greater reduction in 24-h, day-time and night time ABPM values. Lisinopril/HCTZ did not induce significant changes in any of the cognitive function test scores at any time of the study, whereas at both 12 and 24 weeks telmisartan/HCTZ significantly improved the word-list memory score (+17.1 and +15.7%, respectively, P
KW - Cognitive functions
KW - Hypertensive elderly
KW - Lisinopril/HCTZ
KW - Telmisartan/HCTZ
UR - http://www.scopus.com/inward/record.url?scp=33744909553&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33744909553&partnerID=8YFLogxK
U2 - 10.1038/sj.jhh.1001964
DO - 10.1038/sj.jhh.1001964
M3 - Article
C2 - 16306998
AN - SCOPUS:33744909553
VL - 20
SP - 177
EP - 185
JO - Journal of Human Hypertension
JF - Journal of Human Hypertension
SN - 0950-9240
IS - 3
ER -